Alkermes Plc (NASDAQ:ALKS) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a research report issued on Wednesday, AmericanBankingNews.com reports. The firm currently has a $57.00 price target on the stock. Zacks‘s price target points to a potential upside of 19.05% from the company’s current price. Alkermes Plc (NASDAQ:ALKS) stock opened at $46.78 in last session, and closed at $46.32, while the day range of ALKS stock is $45.04-$46.78. The stock showed a negative weekly performance of -4.83%.
Flamel Technologies SA Sponsored ADR’s (FLML) ratings are looking better this week, moving up to an A from last week’s B. Flamel Technologies develops polymer technologies for applications such as drug delivery, biomaterials, and agrochemicals. Flamel Technologies S.A. (ADR) (NASDAQ:FLML) stock opened at $10.54, in last session and closed at $10.10, by loosed -5.70%. The 52 week range was $3.82-$11.48. Company’s market capitalization is $256.70 million.
IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, announced that the Company is scheduled to present at the following two upcoming conferences. 26th Annual Roth Conference on March 10, 2014 at 11:00am (PDT) at The Ritz-Carlton in Dana Point, CA. IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) stock gained 1.75% and finished the last session at $4.07. The EPS of the stock remained -0.35. Company’s market capitalization is $86.37 million.
Acura Pharmaceuticals (NASDAQ:ACUR) had its price objective raised by MLV & Co. from $2.00 to $2.25 in a research report released on Wednesday morning, American Banking News reports. Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) stock opened the session at $1.75, and closed the session at $1.73. The 52 week range of the ACUR stock remained $1.35-$3.78 and the day range was $1.69-$1.75.